Find News

Filter articles

Showing 61 to 70 of 2948 results

EMA unveils fast-track drug shortage monitoring

EU08-04-2020Rory O'Neill

The EU’s drugs regulator has set up a fast-track system to monitor shortages during the COVID-19 pandemic.

EU should buy patent rights for COVID-19 tests, says Greece

Greece07-04-2020Sarah Morgan

Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.  

Shkreli wants Thiola antitrust claims thrown out


Notorious ‘pharma bro’ Martin Shkreli and his former drug company Retrophin want antitrust claims filed against them in federal court dismissed.

Mewburn expands UK IP team


Mewburn Ellis has appointed a new life sciences-focused partner as part of a number of promotions in its IP team.

BIO moves 2020 international convention online

US06-04-2020Sarah Morgan

The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.

UK man charged with smuggling mislabelled COVID-19 kits into US

UK, US03-04-2020Sarah Morgan

A British man has been charged with smuggling mislabelled drugs, purporting to be a treatment for those suffering from COVID-19, into the US. 

Sanofi announces new vaccine project as Australia begins animal tests

Australia, France, US02-04-2020

France’s Sanofi Pasteur and US biotechnology company Translate Bio have joined the race to develop a vaccine for SARS-CoV-2, the coronavirus behind COVID-19.

Gilead fails to overturn $752m BMS patent verdict

US02-04-2020Sarah Morgan

A court has rejected Gilead’s attempt to overturn a $752 million verdict in a patent dispute with BMS’ Juno Therapeutics over CAR-T therapies. 

EIP boosts life sciences practice with Mathys & Squire partner


IP law firm EIP has enhanced its life science capabilities with the addition of Monika Rai as a partner. 

Gilead told to waive remdesivir patent rights

International02-04-2020Rory O'Neill

Almost 150 health and poverty activist campaigns, including Médecins Sans Frontières, have urged Gilead Sciences to waive patent and exclusivity rights for potential COVID-19 treatment remdesivir.

Showing 61 to 70 of 2948 results